A pharmacometrics model to define docetaxel target in early breast cancer
Aims: We aimed to study the relation between pharmacokinetics (PK) and pharmacodynamics (PD) of docetaxel in early breast cancer and recommend a target exposure. Methods: A PK/PD study was performed in 27 early breast cancer patients treated with doxorubicin and cyclophosphamide for 4 cycles foll...
| Príomhchruthaitheoirí: | , , |
|---|---|
| Formáid: | info:eu-repo/semantics/article |
| Teanga: | eng |
| Foilsithe / Cruthaithe: |
Wiley
2023
|
| Ábhair: | |
| Rochtain ar líne: | https://hdl.handle.net/10171/66083 |